关于圣泉
ABOUT HOLY SPRING
立百年圣泉 为人类造福
圣泉集团始建于1979年,总部坐落于济南章丘,占地面积3000余亩,现有员工近4000人,总资产90亿元,是一家致力于各类植物秸秆与高分子树脂材料的研发应用,产业覆盖生物质精炼、高性能树脂及复合材料、铸造辅助材料、健康医药、新能源、卫生防护等领域的创新型企业集团。
认识圣泉
1979
圣泉成立
4000
+
现有员工
500
全国制造业
产业布局
Industrial layout
Biorefinery
“Shengquan method” integrated biorefinery green technology is a technology with true origin innovation at the international level. At present, Shengquan Group is the only enterprise mastering this technology in the world, and has applied for 245 invention patents, of which 112 have been granted. The technology has been included in the Green Technology Promotion Catalog of the National Development and Reform Commission, and spread in the whole China. At present, the world's first 1-million-ton level “Shengquan” integrated biorefinery project (Phase I), invested by Shengquan Group, has been completed in Daqing, Heilongjiang.
查看更多
Phenolic and Composites
High-performance resin and composites industry is the leading industry of Shengquan. Equipped with highly automated phenolic resin workshop with the largest monomer production capacity around the world and the most advanced technology, Shengquan Group can achieve the annual phenolic resin output of 650,000 tons, ranking the 1st in the world.
查看更多
Foundry Materials
Foundry material industry is an advantageous and pillar industry of the Group. The annual output of furan resin, the leading product, is 150,000 tons, ranking the first in the world; Filter products breaking the foreign monopoly have been recognized as the National Torch Program key high-tech products by the Ministry of Science and Technology, ranking the 1st in Asia for production and sales volume; With more than 100 varieties of auxiliary foundry materials, including cold-box resins, pre-coated sand phenolic resins, alkaline phenolic resins, coatings, curing agents, inorganic binders, exothermic-insulating sleeves, and melting materials,
查看更多
Health and Medicals
Shangbo Biotech Co., Ltd., founded as a JV between Shengquan Group and UK Carbosynth Ltd. in 2011, has been focusing on R&D, production and sales of carbohydrates, nucleosides and other pharmaceutical intermediates and APIs. Shangbo has established a multi-functional CGMP workshop in line with EU requirements, and a hydrogenation workshop, which further improves its ability to carry out production transformation in the CDMO market and forms a “R&D – production” system from casual trial, pilot plant test to scale-up production.
查看更多
New Energy
Shandong Shengquan New Energy Technology Co., Ltd was established in 2017 with the registered capital of RMB 200 million. It is a high-tech enterprise dedicated to R&D and manufacturing of long-life battery related fields. The total investment of the first phase of the project is RMB 310 million, mainly including new factories and ancillary facilities, total construction area is 10,439 square meters.
查看更多